About Us
Overview
Strategy
Management
>
Board of Directors
Senior Management
Scientific Advisory Board
Job Opportunities
Clinical Trials
Overview
Products
Advanced Pipeline
>
TroVax
®
ProSavin
®
Hi-8 MEL
®
MetXia
®
RetinoStat
®
Early-stage Pipeline
>
StarGen
®
MoNuDin
®
SMN-1G
Innurex
®
ReQuinate
®
ImmStat
®
EndoAngio-GT
Targeted Antibody
Technology
Gene Delivery Technologies
Gene Discovery and Target Validation
Antibody Delivery
Hypoxia Response Element
Collaborations
Corporate Partnerships
Technology Licence Agreements
Scientific Collaborations and Advisors
Investors
Financing History
Accounts
Share Price
Presentation
>
Interim Results August 2008
Annual General Meeting May 2008
Annual Results March 2007
Web Casts
Announcements
Shareholder Meetings
Contact
News
Announcements
Events
Media Coverage
Contact Us
UK
>
Contacts
Directions
Map
USA
>
Contacts
Directions
Map
Investors
/ Accounts
Downloads
File Size
2008 Interim Report
219K
2007 Reports and Accounts
2007 Interim Report
214K
2006 Reports and Accounts
2006 Interim Report
1,385K
2005 Reports and Accounts
2005 Interim Report
305K
2004 Reports and Accounts
2004 Interim Report
424K
2003 Reports and Accounts
1.51MB
2003
Interim Report
168K
2002 Report and Accounts
1.14MB
2002 Interim Report
299K
2001 Report and Accounts
540K
2001 Interim Report
61K
2000 Report and Accounts
2.2MB
2000 Interim Report
160K
1999 Annual Report
2.1MB
If you cannot view the PDF files above, please click on this link
to download a FREE copy of Acrobat Reader
Website by
College Hill - Life Sciences